Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

[1]  Baoli Liu,et al.  Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role , 2019, Frontiers in Immunology.

[2]  M. van Meurs,et al.  Commentary: Precision Immunotherapy for Sepsis , 2019, Front. Immunol..

[3]  J. Redón,et al.  Urinary podocyte-associated molecules and albuminuria in hypertension , 2018, Journal of hypertension.

[4]  H. Trimarchi.  Podocyturia: Potential applications and current limitations , 2017, World journal of nephrology.

[5]  K. Nath,et al.  A Proposal for a Serology-Based Approach to Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[6]  J. Redón,et al.  Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  J. Politei,et al.  Podocyturia is significantly elevated in untreated vs treated Fabry adult patients , 2016, Journal of Nephrology.

[8]  U. Maggiore,et al.  Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). , 2016, Autoimmunity reviews.

[9]  H. Debiec,et al.  Pathophysiological advances in membranous nephropathy: time for a shift in patient's care , 2015, The Lancet.

[10]  U. Panzer,et al.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[11]  B. Rovin,et al.  Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. , 2013, Journal of the American Society of Nephrology : JASN.

[12]  Jai Radhakrishnan,et al.  Notice , 2012, Kidney International Supplements.

[13]  Belinda Jim,et al.  Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients , 2012, Journal of pregnancy.

[14]  A. McGrogan,et al.  The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  R. Glassock.  The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  C. Ponticelli,et al.  Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? , 2010, Journal of nephrology.

[17]  S. Shankland,et al.  Experimental Models of Membranous Nephropathy. , 2010, Drug discovery today. Disease models.

[18]  J. Nielsen,et al.  The role of podocalyxin in health and disease. , 2009, Journal of the American Society of Nephrology : JASN.

[19]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[20]  J. Ehrich,et al.  Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  R. Wiggins,et al.  The spectrum of podocytopathies: a unifying view of glomerular diseases. , 2007, Kidney international.

[22]  F. Lai,et al.  Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[23]  M. Nangaku,et al.  Cellular response to injury in membranous nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  T. Kajita,et al.  Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. , 2005, Journal of the American Society of Nephrology : JASN.

[25]  M. Hara,et al.  Urinary Podocytes in Primary Focal Segmental Glomerulosclerosis , 2001, Nephron.

[26]  D. C. Cattran,et al.  Idiopathic membranous glomerulonephritis. , 2001, Kidney international.

[27]  G. Camussi,et al.  HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. , 1998, The Journal of clinical investigation.

[28]  N. Gretz,et al.  Progression of glomerular diseases: is the podocyte the culprit? , 1998, Kidney international.

[29]  Tadashi Yamamoto,et al.  Urinary Excretion of Podocytes Reflects Disease Activity in Children with Glomerulonephritis , 1998, American Journal of Nephrology.

[30]  G. Camussi,et al.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells , 1997, Journal of virology.

[31]  D. Kerjaschki,et al.  gp330 and RAP: The Heymann Nephritis Antigenic Complex a , 1994, Annals of the New York Academy of Sciences.

[32]  Notice , 1935, Journal of Symbolic Logic.

[33]  Kathleen N. Lohr,et al.  A Systematic Review of the Literature , 2004 .

[34]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .